K-41B and K-41Bm: New Anti-HIV Compounds from Marine Sources
Author Information
Author(s): Liu Jie, Wei Qiuyu, Liu Xin, Chen Jiang, Zhan Yujie, Li Qinglian, Wang Qian, Liang Bingyu, Jiang Junjun, Qin Fengxiang, Yuan Zongxiang, Qin Qiuzhen, Li Xuehua, Li Yangping, Liang Hao, Ye Li, Zhou Bo, Popovici Violeta
Primary Institution: Guangxi Medical University
Hypothesis
Do K-41B and K-41Bm have different mechanisms of action against HIV-1 compared to their precursor K-41A?
Conclusion
K-41B and K-41Bm exhibit potent anti-HIV-1 activity and may inhibit viral entry, showing mechanisms different from their precursor K-41A.
Supporting Evidence
- K-41B and K-41Bm showed low IC50 values of 0.076 and 0.208 μM, respectively.
- The compounds exhibited high selective indexes of 58.829 and 31.938.
- K-41B and K-41Bm inhibited HIV-1 replication in a dose-dependent manner.
- Molecular docking indicated interactions with key HIV-1 proteins.
- Both compounds blocked cell fusion mediated by viral envelope proteins.
Takeaway
Scientists found two new compounds from the ocean that can help fight HIV. They work differently than an earlier version of the drug.
Methodology
The study used various assays to evaluate the anti-HIV-1 activity of K-41B and K-41Bm, including cell viability, anti-HIV-1 activity, and molecular docking.
Limitations
The study primarily focused on in vitro assays, which may not fully represent in vivo conditions.
Statistical Information
P-Value
0.076 and 0.208 μM for K-41B and K-41Bm respectively
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website